Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries.

Altin M, El-Shafei AA, Yu M, Desaiah D, Treuer T, Zavadenko N, Gao HY.

Drugs Context. 2013 Sep 13;2013:212260. doi: 10.7573/dic.212260. eCollection 2013 Sep 13.

2.

Probabilistic data linkage: a case study of comparative effectiveness in COPD.

Blanchette CM, Dekoven M, De AP, Roberts M.

Drugs Context. 2013 Oct 31;2013:212258. doi: 10.7573/dic.212258. eCollection 2013 Oct 31.

3.

Managing insomnia: an overview of insomnia and pharmacologic treatment strategies in use and on the horizon.

Schwartz TL, Goradia V.

Drugs Context. 2013 Oct 4;2013:212257. doi: 10.7573/dic.212257. eCollection 2013 Oct 4.

4.

Initial combination therapy for patients with type 2 diabetes mellitus: considerations for metformin plus linagliptin.

Freeman JS.

Drugs Context. 2013 Aug 21;2013:212256. doi: 10.7573/dic.212256. eCollection 2013 Aug 21.

5.

Optimizing glycemic control and minimizing the risk of hypoglycemia in patients with type 2 diabetes.

Schwartz SS.

Drugs Context. 2013 May 22;2013:212255. doi: 10.7573/dic.212255. eCollection 2013 May 22.

6.

A new health-related quality of life instrument for leukemia: will it be widely adopted soon?

Yu J, Cheung J.

Drugs Context. 2013 Jun 26;2013:212253. doi: 10.7573/dic.212253. eCollection 2013 Jun 26. No abstract available.

7.

Targeting the metabolism of leukemia stem cells as a novel therapeutic strategy.

Ho EA, Davies NM.

Drugs Context. 2013 Feb 25;2013:212252. doi: 10.7573/dic.212252. eCollection 2013 Feb 25. No abstract available.

8.

Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions.

Kalus JS.

Drugs Context. 2013 Apr 16;2013:212251. doi: 10.7573/dic.212251. eCollection 2013 Apr 16.

9.

Therapeutic approaches to slowing the progression of diabetic nephropathy - is less best?

Vivian E, Mannebach C.

Drugs Context. 2013 Mar 27;2013:212249. doi: 10.7573/dic.212249. eCollection 2013 Mar 27. Review.

10.

Hemodynamic effect of avanafil and glyceryl trinitrate coadministration.

Swearingen D, Nehra A, Morelos S, Peterson CA.

Drugs Context. 2013 Feb 26;2013:212248. doi: 10.7573/dic.212248. eCollection 2013 Feb 26.

11.

Cardiovascular consequences of obesity: how will the UK cope?

Purcell H.

Drugs Context. 2013 Feb 4;2013:212247. doi: 10.7573/dic.212247. eCollection 2013 Feb 4. No abstract available.

12.

Vaccination against meningitis B: is it worth it?

English P.

Drugs Context. 2013 Jan 24;2013:212246. doi: 10.7573/dic.212246. eCollection 2013 Jan 24. No abstract available.

13.

Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary.

Ball SG, Desaiah D, Zhang Q, Thase ME, Perahia DG.

Drugs Context. 2013 Jan 3;2013:212245. doi: 10.7573/dic.212245. eCollection 2013 Jan 3. Review.

14.

Novel therapeutic modalities and drug delivery in pancreatic cancer - an ongoing search for improved efficacy.

Zhang Y, Satoh K, Li M.

Drugs Context. 2012 Dec 11;2012:212244. doi: 10.7573/dic.212244. eCollection 2012 Dec 11.

15.

Is 'GOLD' standard for the management of COPD in clinical practice?

Yawn BP.

Drugs Context. 2012 Nov 26;2012:212243. doi: 10.7573/dic.212243. eCollection 2012 Nov 26. No abstract available.

16.

Metastatic melanoma - a review of current and future drugs.

Velho TR.

Drugs Context. 2012 Nov 19;2012:212242. doi: 10.7573/dic.212242. eCollection 2012 Nov 19. Review.

Supplemental Content

Loading ...
Support Center